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Background: The TIMI frame count (TFC) has been proposed as a
method to assess coronary blood flow. The TFC reflects coronary
flow reserve. Cardiac hypertrophy is associated with a decrease in
coronary reserve. Several factors have been shown to relate with
TFC, but the relation between left ventricular hypertrophy (LVH)
and TFC has not yet been investigated.
Aims and objectives: To determine whether LVH affects TFC.
Materials and Methods: The TFC was measured in 200 subjects
without history of myocardial infarction and significant coronary
stenosis. Determination of left ventricular mass index (LVMI) ac-
cording to the formula of Devereux was performed, and LVH was
defined by LVMI >134 g/m2 in men and >110 g/m2 in women. The
patients were divided into 2 groups according to presence of LVH:
group 1 with LVH (n ¼ 16; aged 51 ± 11 years; 8 women), and group
2 without LVH (n ¼ 18; aged 50 ±8 years; 8 women).
Results: The mean TFC in the right coronary artery (RCA) was
significantly higher in group1 (24,1 ±4,9 frames) than in group 2
(20,9 ±5,4 frames, p ¼ 0.01). The TFC in the RCA was significantly
correlated with interventricular septum thickness (r ¼ 0,36; p ¼
0,004) and left ventricular posterior wall thickness (r ¼ 0,33; p ¼
0,007), but not with LVMI (r ¼ 0.18; p ¼ 0.17). The mean TFC in the
left anterior descending (LAD) and left circumflex (Cx) arteries
were not different between the two groups. No correlation existed
between TFC in the LAD or LCx and echocardiographic
parameters.
Conclusions: Left ventricular hypertrophy has significant effect
on the TFC in the RCA but not in LAD and LCX. Therefore, studies
comparing TFC need to consider LVH.
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Background: Antiplatelet therapy with platelet P2Y12 receptor
antagonists is a cornerstone of antithrombotic treatment in pa-
tients. Since the data is largely derived from clinical trials, the
TREASURE observational study is designed to address the need to
understand the usage pattern of Ticagrelor in real life scenario in
large number of ACS patients in India. To our knowledge, it will be
largest ever antiplatelet agent related observational study in real
world scenario in India.
Objectives: To describe the usage pattern of Ticagrelor in various
ACS patient population who undergo either PCI, CABG or medical
management in a real-life setting from 60 different centers in
India.
Methods: This is an observational, multi-centric, prospective
study. Study proposes to include 3000 subjects from 60 centres
across India. Key inclusion Criteria would be provision of subject
informed consent and Patients who had been hospitalized for ACS
and are on ticagrelor on discharge or on Ticagrelor therapy for 
1month will be enrolled in the study and followed up for a period
of 12 months. Demographic data, Diagnosis (type of ACS), Man-
agement of ACS, Laboratory Investigations, relevant history,
physical examination will be collated.
Results: Study is expected to fill a significant gap exists in our
knowledge to understand the usage pattern of Ticagrelor in real
life scenario in large number of ACS patients in India. The aim of
this national study is to understand the usage pattern (including
the duration of treatment) of Ticagrelor in various ACS patient
population undergoing PCI, CABG or medical management in a
real-life setting in India.
Moreover, patients with various risk factors [i.e. elderly pa-
tients, diabetes, renal impairment, smoking, GRACE risk score)
and their association with ACS and Ticagrelor usage will be
measured. Study also intends to record any clinical event (CV
event, Bleeding etc) during the follow up period of the study.
Conclusion: The multicenter national study will allow generating
real life evidence by involving patients from different geographies
and healthcare systems in India. The study is intended to provide
useful evidence of the ticagrelor usage in variety of ACS patients
in actual hospital settings. Along with the PLATO study result; this
data will be extremely useful to optimize ACS management in
India in order to save more lives.
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Background: Primary percutaneous coronary intervention (PCI)
is the treatment of choice for patients presenting with acute ST-
segment elevation myocardial infarction (STEMI). However, if
catheterization facilities are not immediately available (e.g.
countries like India) the effectiveness of PCI can be affected by
delays in transfer. Evidence suggests that antiplatelet therapy
administered early, preferably in the ambulance during transfer,
may provide better and earlier perfusion. Ticagrelor, a direct
platelet P2Y12 receptor inhibitor, is indicated for themanagement
of patients with acute coronary syndromes. In India, a large scale
Kerala ACS registry, found big time delay between ACS (Acute
Coronary Patients) symptom and PCI. In this scenario, it was
important to evaluate implications of ATLANTIC (Administration
of Ticagrelor in the cath Lab or in the Ambulance for New ST
elevation myocardial Infarction to open the Coronary artery)
study in Indian scenario. This analysis is imperative in the view of
the fact that the latest European Society of Cardiology (ESC) 2014
myocardial revascularization guidelines recommended P2Y12
inhibitors to be given at first medical context for patient under-
going primary PCI.
Aim: To evaluate whether earlier, in-ambulance or administration
of Ticagrelor could safely improve coronary reperfusion in pa-
tients with STEMI transferred for PCI.
Methods: ATLANTIC is an international,multicenter, randomized,
double-blind study involving 1862 patients with ongoing STEMI of
less than 6 hours duration, comparing pre-hospital (in the
ambulance) versus in-hospital (in the catheterization laboratory)
treatment with Ticagrelor. The co-primary end points were the
proportion of patients who did not have a 70% or greater resolu-
tion of ST-segment elevation before percutaneous coronary
intervention (PCI) and the proportion of patients who did not have
Thrombolysis in Myocardial Infarction flow grade 3 in the infarct-
related artery at initial angiography. Secondary end points
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included the rates of major adverse cardiovascular events and
definite stent thrombosis at 30 days.
Results: The median time from randomization to angiography
was 48 minutes, and the median time difference between the two
treatment strategies was 31 minutes. The two co-primary end
points did not differ significantly between the pre-hospital and in-
hospital groups (86.8% vs 87.6% and 82.6% vs 83.1% respectively,
p¼NS). The rates of major adverse cardiovascular events did not
differ significantly between the two study groups. The rates of
definite stent thrombosis were lower in the pre-hospital group
than in the in-hospital group (0% vs. 0.8% in the first 24 hours,
p¼0.008; 0.2% vs. 1.2% at 30 days, p¼0.02). Rates of major bleeding
events were low and virtually identical in the two groups.
Conclusion: Pre-hospital administration of Ticagrelor in patients
with acute STEMI appeared to be safe but did not improve pre-PCI
coronary reperfusion. It may, however, reduce the risk of post-PCI
stent thrombosis. Results are also aligned with the new ESC 2014
Guidelines which recommended P2Y12 inhibitors to be given at
first medical context for patient undergoing primary PCI. These
will particularly suitable in India where patients are arriving late
at the cath lab centers. For STEMI patients undergoing PCI, it is
advisable to give Ticagrelor in pre-hospital (in Ambulance or at
secondary care) setting in Indian scenario.
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Background: Obese patients with established coronary artery dis-
ease (CAD) have reduced mortality compared to normal or low
body mass index (BMI) patients, irrespective of whether treated
with medically, percutaneous coronary intervention (PCI) or cor-
onary artery bypass surgery (CABG). The reason for theparadoxicU
or J-shaped relation between BMI and adverse outcome is not yet
clearly understood. We sought to evaluate the association of BMI
and waist circumference at the time of presentation in patients
with myocardial infarction with one-year adverse cardiac events.
Methods: In this prospective cohort study we included consecu-
tive patients with acute myocardial infarction (MI) admitted to a
tertiary care hospital during a period of one year .Upon admission,
BMI and waist circumference were measured. Patients were fol-
lowed-up for a period of one year for primary composite outcome
of death or nonfatal MI and correlated with BMI and waist
circumference categories. Body mass index was classified as un-
derweight (BMI <18.5 kg/m2), normal weight (18.5-22.9 kg/m2),
overweight (23-24.9 kg/m2), obese class I (25 to 29.9 kg/m2) or obese
class II (>30 kg/m2).Waist circumference greater than 90 cm in
men and 80 cm in women was categorized high.
Results: There were 703 patients (males 559 (79.5%), females 144
(20.4%)). Among them 100(14.2%) were underweight, 351(49.9%)
were of normal weight and 122 (17.3%) were overweight. Class I
obesity was seen in 112 (15.9%) and class II obesity in 18(2.5%)
patients. There were 227(32%) patients with high waist circum-
ference. Over a period of one year, there were 40 (5.6%) deaths
including 18 in-hospital deaths. Combined nonfatal MI and death
at one year was 128(18.2%). Incidence of primary outcome was
25.0% in low BMI group, 19.9% in normal BMI group, 13.1% in
overweight group, 13.4 % in obese class I and 11.1 % in obese class
II group. In univariate analysis, the inverse correlation of obesity
and primary outcome was significant by linear-by-linear associ-
ation (p value¼ 0.007). In-hospital mortality showed no significant
correlation with obesity parameters. In one year follow up period,
12.8% in high waist circumference group and 20.8 % in normal
waist circumference group had primary outcome (P value¼0.01).
In-hospital mortality was 2.5% in high waist circumference group
and 3.4% in normal waist circumference group (P value ¼ 0.052).
Both BMI and waist circumference lost their predictive value in
multivariate analysis.
Conclusions: Low BMI and normal waist circumference were
associated with a worse short term outcome in patients with
acute MI. After adjusting for other variables, neither BMI nor waist
circumference independently predicted cardiac events or death
after acute MI.
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Background: The higher risk for coronary heart disease (CHD) in
South Asians at a younger age is attributed to the higher levels of
conventional risk factors. However, cardiac rehabilitation (CR) is
yet to gain momentum in the subcontinent. We aimed to analyse
the factors that influence participation in a CR program in a single
center in South India.
Methods: All patients referred for CR between May and July 2014
were included. Age, gender, work status, residence address, past
medical history and treatment history were documented. A
typical CR program (TCR) included 24 sessions spread over 12
weeks, each session lasting 90 minutes. A modified CR program
(MCR) had fewer sessions and a home-based CR program (HCR)
was followed at home with a monthly visit to the CR facility. Pa-
tients weremotivated by the physician to attend group sessions at
a fixed schedule based on their convenience. CR was exercise-
based with education on balanced diet andstress management,
and psychosocial counseling.
Results: The study cohort included 24 patients with coronary
heart disease (58±9 years,88%males). Working individuals (n¼17),
retired people (n¼5) and homemakers (n¼2) constituted the
cohort. While majority lived in the same city as the CR facility, 8
(33%) resided outside thecity with commute time >3 hours. CR
program was attended by 14 (58%) subjects of which 8 (57%) were
TCR, 5 (36%) MCR and 1(7%) HCR. Of the 10 patients not following a
CR program, long distance (n¼8), dependent family member (n¼1)
anddebilitating spinal tuberculosis (n¼1) were the reasons.
Conclusions: Secondary prevention of CHD is the definitive solu-
tion to the growing rate of complications and spiraling healthcare
costs in India. This study has demonstrated that patients can be
motivated to attend a comprehensive CR program, with some
modification to suit their requirements. Lack of easily accessible
CR facilities is a deterring factor for participation.
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